TP53 and neoplasm: PRIMA-1 (p53 reactivation and induction of massive apoptosis) is a small molecular drug that was functionally discovered to reactivate mutant p53 by restoring its WT (wild type) protein conformation, transcriptional activity and its ultimate tumour suppressive properties [9, 10].